Cargando…

Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer

OBJECTIVE: To measure Met protein content in prostate biopsies guided by fused magnetic resonance and ultrasound imaging, and to measure soluble Met (sMet) protein concentration in plasma samples from patients presenting evidence of prostate cancer. PATIENTS AND METHODS: 345 patients had plasma samp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaye, Deborah R., Pinto, Peter A., Cecchi, Fabiola, Reilly, Joseph, Semerjian, Alice, Rabe, Daniel C., Gupta, Gopal, Choyke, Peter L., Bottaro, Donald P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907470/ https://www.ncbi.nlm.nih.gov/pubmed/27300295 http://dx.doi.org/10.1371/journal.pone.0157130

Ejemplares similares

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
por: Shah, Manish A., et al.
Publicado: (2021)

Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer
por: Shah, Manish A., et al.
Publicado: (2022)

Novel Antagonists of Heparin Binding Growth Factors
por: Cecchi, Fabiola, et al.
Publicado: (2012)

Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder
por: McNeil, Brian K, et al.
Publicado: (2014)

Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors
por: Kummar, Shivaani, et al.
Publicado: (2021)

Absolute Quantitation of Met Using Mass Spectrometry for Clinical Application: Assay Precision, Stability, and Correlation with MET Gene Amplification in FFPE Tumor Tissue
por: Catenacci, Daniel V. T., et al.
Publicado: (2014)

Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells
por: Chu, Chia, et al.
Publicado: (2016)

Hepatocyte growth factor/MET in cancer progression and biomarker discovery
por: Matsumoto, Kunio, et al.
Publicado: (2017)

Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder
por: Lee, Young H., et al.
Publicado: (2014)

RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization
por: Chu, Gina Chia-Yi, et al.
Publicado: (2014)

MET Inhibition in Clear Cell Renal Cell Carcinoma
por: Xie, Zuoquan, et al.
Publicado: (2016)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
por: An, Julie Y., et al.
Publicado: (2017)

Functional MRI in Prostate Cancer Detection
por: Sankineni, Sandeep, et al.
Publicado: (2014)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers
por: Lochrin, Sarah E., et al.
Publicado: (2021)

MET expression during prostate cancer progression
por: Verhoef, Esther I., et al.
Publicado: (2016)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)

The Role of MRI in Prostate Cancer Active Surveillance
por: Johnson, Linda M., et al.
Publicado: (2014)

Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin
por: Mak, Blossom, et al.
Publicado: (2022)

Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC
por: Jie, Guang-Ling, et al.
Publicado: (2023)

Is Visual Registration Equivalent to Semiautomated Registration in Prostate Biopsy?
por: Kwak, Jin Tae, et al.
Publicado: (2015)

Sprouty-2 Controls c-Met Expression and Metastatic Potential of Colon Cancer Cells: Sprouty/c-Met Upregulation in Human Colonic Adenocarcinomas
por: Holgren, Cory, et al.
Publicado: (2010)

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma
por: Catenacci, Daniel V. T., et al.
Publicado: (2016)

Efficacy of c-Met inhibitor for advanced prostate cancer
por: Tu, William H, et al.
Publicado: (2010)

Effects of testosterone replacement on serotonin levels in the prostate and plasma in a murine model of hypogonadism
por: Mota, Paulo, et al.
Publicado: (2020)

Early Experiences of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Treatment in Localized Prostate Cancer
por: Ko, Christine, et al.
Publicado: (2012)

Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI
por: Mayer, Rulon, et al.
Publicado: (2023)

Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment options
por: Chaurasia, Avinash R, et al.
Publicado: (2020)

Plasma-seq: a novel strategy for metastatic prostate cancer analysis
por: Farris, Caitlin, et al.
Publicado: (2013)

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Genome-wide plasma DNA methylation features of metastatic prostate cancer
por: Wu, Anjui, et al.
Publicado: (2020)

Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma
por: Adachi, Eri, et al.
Publicado: (2016)

Whole Prostate Volume and Shape Changes with the Use of an Inflatable and Flexible Endorectal Coil
por: Osman, Murat, et al.
Publicado: (2014)

EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205
por: Massoner, P, et al.
Publicado: (2014)

Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
por: Wang, Jieyi, et al.
Publicado: (2016)

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors
por: Shuch, Brian, et al.
Publicado: (2015)

A receptor-antibody hybrid hampering MET-driven metastatic spread
por: Modica, Chiara, et al.
Publicado: (2021)

Targeting c-MET to Enhance the Efficacy of Olaparib in Prostate Cancer
por: Wang, Zhenwei, et al.
Publicado: (2021)

Computer Aided-Diagnosis of Prostate Cancer on Multiparametric MRI: A Technical Review of Current Research
por: Wang, Shijun, et al.
Publicado: (2014)

Multiplexed Exchange-PAINT imaging reveals ligand-dependent EGFR and Met interactions in the plasma membrane
por: Werbin, Jeffrey L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_juk9kfb548n5f3m5ebuo1jq1s3